St. Jude Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

STJ 50.40 +0.94 (1.90%)
price chart
St. Jude Medical Inc. (STJ) Falls 2.56% for February 11
One of the S&P 500's big losers for Thursday February 11 was St. Jude Medical Inc. (STJ). The company's stock fell 2.56% to $49.42 on volume of 1.42 million shares.
St. Jude Medical, Inc. (STJ) VP Sells $538197.68 in Stock  Financial Market News
Stock In News: St. Jude Medical, Inc. (NYSE:STJ)  Vanguard Tribune
St. Jude Medical, Inc. 5.6% Potential Upside Now Implied by Canaccord Genuity
St. Jude Medical, Inc. with TICKER NYSE:STJ had its stock rating noted as 'Upgrade' with the recommendation being set at 'HOLD' yesterday by research analysts at Canaccord Genuity.
St. Jude Medical, Inc. (STJ) Upgraded to Hold by Canaccord Genuity  Financial Market News
Jeff Fecho Sells 10408 Shares of St. Jude Medical, Inc. (STJ) Stock  Intercooler Financial
St. Jude Medical, Inc. (STJ) Position Increased by DNB Asset Management
St. Jude Medical logo DNB Asset Management raised its position in shares of St. Jude Medical, Inc. (NYSE:STJ) by 584.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
118245 Shares in St. Jude Medical, Inc. (STJ) Acquired by Capital Fund ...  The Vista Voice
St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the company's OPTIS™ Mobile System in Japan and Europe.
St Jude Medical is Oversold
But making St Jude Medical Inc an even more interesting and timely stock to look at, is the fact that in trading on Wednesday, shares of STJ entered into oversold territory, changing hands as low as $52.045 per share.
Q1 2017 EPS Estimates for St. Jude Medical, Inc. Cut by Analyst (STJ)
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) - Equities research analysts at Leerink Swann cut their Q1 2017 EPS estimates for shares of St. Jude Medical in a research report issued to clients and investors on Monday, according to Zacks ...
St. Jude Medical Announces FDA Approval of the Proclaim Elite SCS System, a ...
BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company and an international leader in chronic pain therapy development, today announced FDA approval of the new Proclaim™ Elite Spinal Cord Stimulation System, the first ...
St. Jude Medical Gets FDA Approval For Proclaim Elite SCS System  Nasdaq
St. Jude earns FDA approval for recharge-free spinal cord stimulation system  FierceMedicalDevices (press release) (registration)
St. Jude Medical's OPTIS Mobile System in Japan & Europe
We believe St. Jude's OPTIS Mobile System will provide improved options to physicians performing PCI procedures with its combination of OCT and FFR.
St. Jude Launches Mobile OCT/FFR/Angio System for Cath Labs in Europe and Japan  Angioplasty.Org
St. Jude Medical Offers Weak Profit Outlook
St. Jude Medical Inc. on Wednesday offered weak profit forecasts for 2016 as the company continues to face pressure in its cardiac rhythm segment.
St. Jude Medical, Inc. (STJ) Price Target Cut to $54.00 by Analysts at ...  EMQ
St. Jude Medical Announces 2016 Annual Analyst and Investor Meeting
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, will hold its 2016 Annual Analyst and Investor Meeting on Friday, Feb. 5, 2016, from 8 a.m.
Jefferies Group Reiterates "Hold" Rating for St. Jude Medical, Inc ...  EMQ